Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfizer Inc, NY, NY 10017, NDC 0025-1031-31
Published November 27, 2013 · Recall initiated: September 4, 2013
Summary
FDA records drug Class II recall D-014-2014, published November 27, 2013 and initiated September 4, 2013. Recalling firm: Pfizer Us Pharmaceutical Group; Status: Terminated; Reported quantity: 31 bottles; Lot: Lot #: V121573, Exp 05/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
What to do
Voluntary: Firm initiated · Letter
Get an email if ALDACTONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ALDACTONE
- Manufacturer
- Pfizer Us Pharmaceutical Group
- Distributor
- US Nationwide
- UPC
- 0300251001314
- Lot
- Lot #: V121573, Exp 05/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOndansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., LakeNovember 27, 2013
- FDAAffirm XL Nutritional Supplement, 1 and 10 count blister packs and single pill packs, Manufactured by DongseoNovember 27, 2013
- FDAMetoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., LakeNovember 27, 2013
- FDACellulase Enzyme Blends, bulk, custom blended formulations identified as Cellulase BX and Celluase Conc,November 27, 2013
- FDASpironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJNovember 27, 2013
- FDAPectinase Enzyme Blends, bulk, custom blended formulations identified as pectinase 500, pectinase 1000,November 27, 2013
Questions about this recall
Was Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfizer Inc, NY, NY 10017, NDC 0025-1031-31 recalled?
Yes. FDA published recall D-014-2014 on November 27, 2013. Reported hazard: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ALDACTONE. UPC: 0300251001314.